基于益生菌碳水化合物的有针对性输送方面的进展:克服生物活性成分的胃肠道挑战
Yunzhen Zhang1, Jian He2, Hong Zeng1
1School of Food and Health, Beijing Technology and Business University, Haidian, 100048, Beijing, PR China.
Food chemistry
|November 30, 2024
概括
益生菌碳水化合物矩阵增强了天然生物活性成分的口服生物可用性. 这些有针对性的输送系统改善了胃肠道屏障的穿越和释放,有利于食品和健康应用.
科学领域:
- 营养科学 营养科学
- 生物材料科学 生物材料科学
- 药理学 药理学是指药理学的学科.
背景情况:
- 天然生物活性成分往往表现为口服生物可用性较差,限制了它们的治疗和功能应用.
- 有效的输送系统对于克服胃肠道障碍和实现这些化合物的向释放至关重要.
- 益生菌碳水化合物为开发先进的输送系统提供了一个有希望的矩阵.
研究的目的:
- 综合审查使用益生菌碳水化合物矩阵的有针对性的输送系统.
- 探索这些系统的结构,释放机制和应用.
- 为开发和应用基于益生菌碳水化合物的传递系统在食品和健康领域提供见解.
主要方法:
- 对生物活性成分的向输送系统的文献审查.
- 封装方法的分析,包括纳米水凝,纳米颗粒,纳米乳液,微/纳米囊和纳米纤维.
- 检查由结肠环境 (pH,粘液,微生物群,酶) 影响的释放机制.
主要成果:
- 益生菌碳水化合物矩阵可以将生物活性成分封装成各种纳米和微结构,以控制释放.
- 通过与特定生理因素的相互作用来实现对结肠的向输送.
- 由结肠微生物群发酵的前生物碳水化合物产生有益的后生物.
结论:
- 基于益生菌碳水化合物的向输送系统提供了一种可行的策略,以改善天然生物活性成分的口服生物可用性.
- 这些系统有助于控制释放和有针对性的输送到结肠,提高食品和卫生部门的有效性.
- 益生菌碳水化合物的双重功能 (输送矩阵和微生物群调节器) 对未来的发展具有重大潜力.
相关概念视频
Factors Influencing Bioavailability: First-Pass Elimination
6.1K
When a drug is taken orally, it undergoes a journey starting from the gastrointestinal (GI) tract, passing through the portal vein, reaching the liver, and finally entering the systemic circulation. This process involves the absorption of the drug across the GI tract. The liver is the primary site for metabolizing the drug, with some metabolism also occurring in the gut wall. This journey significantly reduces the quantity of the drug that reaches the systemic circulation, a phenomenon known as...
6.1K
Drug Delivery: Overview
278
The selection of a drug's delivery route depends upon its physicochemical properties, including lipid or water solubility and ionization, as well as the therapeutic requirement, such as immediate or sustained effect. These routes can be divided into three primary categories: enteral, parenteral, and topical.
Enteral delivery involves administering drugs directly through swallowing, sublingual placement, or buccal application. Orally administered drugs predominantly navigate the...
Enteral delivery involves administering drugs directly through swallowing, sublingual placement, or buccal application. Orally administered drugs predominantly navigate the...
278
Factors Affecting Dissolution: Drug Permeability, Stability and Stereochemistry
177
Orally administered drugs primarily enter the systemic circulation via passive diffusion through the intestinal membranes. The drug's absorption is influenced by drug stability in the gastrointestinal GI tract, membrane permeability, the surface area available for absorption, luminal drug concentration, and residence time in the lumen. Drug permeability can be enhanced by adjusting the lipophilicity, polarity, or molecular size of the drug, promoting its passive transport across intestinal...
177
Carrier-Mediated Transport
278
Carrier-mediated transport is a pivotal process in drug absorption, particularly for lipid-insoluble drugs, and encompasses facilitated diffusion and active transport. Facilitated diffusion allows drugs to move along their concentration gradient without energy expenditure, while active transport utilizes ATP to drive drug movement against this gradient.
Active transport involves two types of membrane-spanning transporters: uptake and efflux. Uptake transporters are expressed in the small...
Active transport involves two types of membrane-spanning transporters: uptake and efflux. Uptake transporters are expressed in the small...
278
Factors Influencing Drug Absorption: Physicochemical Parameters
237
The physicochemical characteristics of drugs play a crucial role in formulating stable and bioavailable drug products. The solubility of a drug, governed by the varying pH along the GI tract and its dissociation constant (pKa), is pivotal in determining its ionization state and absorption rate. Notably, weak acids and bases remain unionized and are absorbed more rapidly.
Enhanced drug absorption can be achieved by reducing particle sizes and increasing surface areas, thereby facilitating...
Enhanced drug absorption can be achieved by reducing particle sizes and increasing surface areas, thereby facilitating...
237
Drug Delivery: Enteral Route
383
The enteral drug administration involves three primary routes: oral, sublingual, and buccal. Oral ingestion is the most prevalent, safe, economical, and convenient method for drug administration. However, it has certain drawbacks, including limited absorption due to the drug's low water solubility or poor membrane permeability, possible emesis from GI mucosa irritation, destruction of drugs by digestive enzymes or low gastric pH, and irregular absorption along with food or other drugs.
383


